JESSICA MCNISH: Open Payments
NPI 1861154361 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,451 in 43 payments from 8 companies in 2025. Trend: 2023 $1,895 · 2024 $2,052 · 2025 $1,451
Food & beverage: $1,144Travel & lodging: $307
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 11 | $667 |
| CVRx, Inc. | 16 | $309 |
| Alnylam Pharmaceuticals Inc. | 7 | $132 |
| E.R. Squibb & Sons, L.L.C. | 1 | $116 |
| BridgeBio Pharma, Inc. | 1 | $93 |
| Novartis Pharmaceuticals Corporation | 3 | $48 |
| Merck Sharp & Dohme LLC | 3 | $46 |
| PFIZER INC. | 1 | $42 |
Products named: CARDIOMEMS, Barostim Neo System, CAMZYOS, ONPATTRO, Attruby, LEQVIO, VERQUVO, VYNDAQEL.
Industry payments across TX — which companies pay providers there.
